PHXM Annual Cash & Cash Equivalents
$41.60 M
+$3.44 M+9.02%
31 December 2022
Summary:
As of January 31, 2025, PHXM annual cash & cash equivalents is $41.60 million, with the most recent change of +$3.44 million (+9.02%) on December 31, 2022. During the last 3 years, it has fallen by -$40.37 million (-49.25%).PHXM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Quarterly Cash And Cash Equivalents
N/A
30 September 2023
Summary:
PHXM quarterly cash and cash equivalents is not available.PHXM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.0% | - |
| 3 y3 years | -49.3% | - |
| 5 y5 years | -81.3% | - |
PHXM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -81.3% |
PHAXIAM Therapeutics SA Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $27.37 M(-34.2%) |
| Dec 2022 | $41.60 M(+9.0%) | $41.60 M(-25.3%) |
| June 2022 | - | $55.72 M(+46.0%) |
| Dec 2021 | $38.15 M(-30.2%) | $38.15 M(-30.8%) |
| June 2021 | - | $55.13 M(+0.8%) |
| Dec 2020 | $54.67 M(-33.3%) | $54.67 M(+7.0%) |
| June 2020 | - | $51.10 M(-37.7%) |
| Dec 2019 | - | $81.97 M(-8.6%) |
| Dec 2019 | $81.97 M(-46.7%) | - |
| Sept 2019 | - | $89.64 M(-16.5%) |
| June 2019 | - | $107.39 M(-30.1%) |
| Dec 2018 | - | $153.71 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $153.71 M(-30.9%) | - |
| June 2018 | - | $191.26 M(-14.1%) |
| Dec 2017 | $222.57 M(+459.3%) | $222.57 M(+119.7%) |
| June 2017 | - | $101.30 M(+154.5%) |
| Dec 2016 | $39.80 M(-20.2%) | $39.80 M(-1.9%) |
| June 2016 | - | $40.57 M(-18.7%) |
| Dec 2015 | $49.89 M(+10.9%) | $49.89 M(+43.3%) |
| June 2015 | - | $34.82 M(-22.6%) |
| Dec 2014 | $44.98 M(+115.5%) | $44.98 M(+168.3%) |
| June 2014 | - | $16.76 M(-19.7%) |
| Dec 2013 | $20.87 M(+100.4%) | $20.87 M(-13.3%) |
| June 2013 | - | $24.06 M(+131.0%) |
| Dec 2012 | $10.41 M | $10.41 M |
FAQ
- What is PHAXIAM Therapeutics SA annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual cash & cash equivalents year-on-year change?
- What is the all time high quarterly cash and cash equivalents for PHAXIAM Therapeutics SA?
What is PHAXIAM Therapeutics SA annual cash & cash equivalents?
The current annual cash & cash equivalents of PHXM is $41.60 M
What is the all time high annual cash & cash equivalents for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual cash & cash equivalents is $222.57 M
What is PHAXIAM Therapeutics SA annual cash & cash equivalents year-on-year change?
Over the past year, PHXM annual cash & cash equivalents has changed by +$3.44 M (+9.02%)
What is the all time high quarterly cash and cash equivalents for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly cash and cash equivalents is $222.57 M